Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/110765
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technologyen_US
dc.creatorGuo, XCen_US
dc.creatorShi, DZen_US
dc.creatorHuang, Sen_US
dc.creatorZhang, YHen_US
dc.creatorZhang, WYen_US
dc.creatorChen, Jen_US
dc.creatorHuang, Zen_US
dc.creatorWu, Hen_US
dc.creatorHou, JQen_US
dc.creatorJin, FJen_US
dc.creatorChen, XCen_US
dc.creatorWong, WLen_US
dc.creatorLu, YJen_US
dc.date.accessioned2025-01-24T03:07:32Z-
dc.date.available2025-01-24T03:07:32Z-
dc.identifier.issn1520-4804en_US
dc.identifier.urihttp://hdl.handle.net/10397/110765-
dc.language.isoenen_US
dc.publisherAmerican Chemical Societyen_US
dc.rights© 2025 American Chemical Societyen_US
dc.rightsThis document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Medicinal Chemistry, copyright © 2025 American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acs.jmedchem.4c02121.en_US
dc.subjectBiological imagingen_US
dc.subjectCellsen_US
dc.subjectPeptides and proteinsen_US
dc.subjectProbesen_US
dc.subjectTumorsen_US
dc.titlePET imaging of solid tumors with a G-quadruplex-targeting ¹⁸F-labeled peptide probeen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage2804en_US
dc.identifier.epage2814en_US
dc.identifier.volume68en_US
dc.identifier.issue3en_US
dc.identifier.doi10.1021/acs.jmedchem.4c02121en_US
dcterms.abstractPositron emission tomography (PET) is a common imaging technique and can provide accurate information about the size, shape, and location of tumors. Recent evidence has shown that G-quadruplex structures (G4s) are identified in human oncogenes, and these special structures are recognized as diagnostic cancer markers and drug targets for anticancer therapies. Although a number of techniques for in vivo imaging of G4s have been developed, achieving sufficient sensitivity and selectivity in vivo remains challenging. Herein, we have engineered and developed a radiolabeled peptide probe [18F]AlF-NOTA-RHAU18 targeting mitochondrial DNA G4s for in vivo PET imaging. The results of the study indicate that this probe is able to visualize and detect solid tumors in living homozygous mice. In addition, the distribution of the probe in cancer cells was investigated using FITC-RHAU18. This work may offer new insights into the development of cancer diagnostic tools by targeting in vivo G4s.en_US
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationJournal of medicinal chemistry, 13 Feb. 2025, v. 68, no. 3, p. 2804-2814en_US
dcterms.isPartOfJournal of medicinal chemistryen_US
dcterms.issued2025-02-13-
dc.identifier.eissn0022-2623en_US
dc.description.validate202501 bcwhen_US
dc.description.oaAccepted Manuscripten_US
dc.identifier.FolderNumbera3375-
dc.identifier.SubFormID50018-
dc.description.fundingSourceSelf-fundeden_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryGreen (AAM)en_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Guo_PET_Imaging_Solid .pdfPre-Published version4.02 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Final Accepted Manuscript
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

13
Citations as of Apr 14, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.